Multicenter placebo-controlled study of nedocromil sodium 1% nasal solution in ragweed seasonal allergic rhinitis

H. M. Druce, S. Goldstein, J. Melamed, J. Grossman, B. A. Moss, R. G. Townley

Research output: Contribution to journalArticle

21 Scopus citations

Abstract

An 8-week double-blind study was carried out in 177 ragweed patients with seasonal allergic rhinitis to compare nedocromil sodium 1% nasal solution (Tilarin(R), QID, Fisons plc) and placebo. Symptoms of rhinitis were significantly reduced by nedocromil sodium during the peak 3-week pollen season (P=.001 for diary summary score) and the active treatment was rated effective by 74% of patients.

Original languageEnglish (US)
Pages (from-to)212-216
Number of pages5
JournalAnnals of allergy
Volume65
Issue number3
StatePublished - Jan 1 1990

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy

Cite this

Druce, H. M., Goldstein, S., Melamed, J., Grossman, J., Moss, B. A., & Townley, R. G. (1990). Multicenter placebo-controlled study of nedocromil sodium 1% nasal solution in ragweed seasonal allergic rhinitis. Annals of allergy, 65(3), 212-216.